Assenagon Asset Management S.A. Grifols Sa Transaction History

Assenagon Asset Management S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 01, 2021	SELL	$16.86 - $19.67 $4.51 Million - $5.26 Million	-267,377 Closed	0 $0
Q3 2020 Oct 07, 2020	SELL	$15.4 - $20.16 $11 Million - $14.4 Million	-716,334 Reduced 72.82%	267,377 $4.64 Million
Q2 2020 Jul 21, 2020	BUY	$18.24 - $21.45 $13.5 Million - $15.9 Million	740,367 Added 304.25%	983,711 $17.9 Million
Q1 2020 Apr 17, 2020	BUY	$16.28 - $25.63 $3.96 Million - $6.24 Million	243,344 New	243,344 $4.9 Million

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.